Yes. Amyotrophic lateral sclerosis is a qualifying condition under the Texas Compassionate Use Program. The patient must also be a permanent Texas resident, and qualification does not make the prescription automatic. Our doctors review the diagnosis, symptom burden, medications, swallowing and breathing concerns, mobility, caregiver observations, and whether the risk of low-THC cannabis is reasonable in light of the potential benefit. If prescribed, the physician enters the prescription into CURT. Patients don't register themselves, pay a separate state registration fee, or receive a physical medical marijuana card.
ALS changes faster than most families expect. A person may first notice a weak hand, a foot that catches, muscle twitching, or speech that sounds slightly different. Later, the practical questions become more urgent: Is pain interrupting sleep? Are cramps making transfers harder? Is swallowing safe? Has a medication added fatigue to an already exhausting day?
Those are the details our physicians need. We aren't evaluating ALS as a word on a problem list. We are looking at the person living with it, the pace of change, the care team already involved, and the symptoms that are taking the greatest toll right now.
A medical marijuana doctor in Texas may consider a prescription for symptom management, but medical cannabis doesn't stop motor neuron loss, reverse weakness, or replace an ALS clinic, neurology care, respiratory support, nutrition planning, therapy, or disease-modifying treatment.
What we want families to understand: ALS care is already medically complex. Adding cannabis should solve a clearly defined problem without creating a new one, such as more sedation, poorer balance, confusion, or difficulty communicating.
Amyotrophic lateral sclerosis, often called ALS or Lou Gehrig's disease, is a progressive neurological condition that damages the motor neurons responsible for voluntary movement. As those nerve cells stop working, muscles weaken and waste away.
The pattern isn't identical for everyone. ALS may begin in a hand, arm, leg, speech muscles, or muscles involved in swallowing. Muscle cramps, twitching, stiffness, spasticity, fatigue, slurred speech, falls, and loss of dexterity can appear at different points. Breathing becomes a major concern as respiratory muscles weaken.
Sensation is often relatively preserved, which can be difficult for families to understand. The person may feel a touch or discomfort normally while losing the muscle strength needed to move, speak, cough, swallow, or reposition independently.
All three are neurological conditions, but they affect the nervous system differently. ALS primarily damages motor neurons. Multiple sclerosis involves immune-mediated damage to myelin in the central nervous system, while Parkinson's disease is associated with changes in movement control that commonly include tremor, rigidity, and slowness. The diagnosis matters because the medical risks, expected course, and treatment goals differ.
ALS is specifically listed as a qualifying condition under Texas law. A permanent Texas resident with a medically supported diagnosis may be evaluated by a qualified physician participating in the state program.
Legal eligibility doesn't guarantee that low-THC cannabis is the right choice at every stage of the disease. Our physicians still need enough reliable information to determine whether the risk is reasonable in light of the potential benefit. Neurology notes, ALS clinic records, medication lists, respiratory information, feeding-tube history, therapy reports, and caregiver observations may all help.
Patients comparing diagnoses can review our guide to qualifying conditions for medical marijuana in Texas.
No. ALS allows a qualified physician to consider low-THC cannabis under Texas law. The physician still decides whether the statutory risk-benefit standard is met based on the patient's current symptoms, medications, medical stability, goals, and safety profile.
The first question isn't “How advanced is the ALS?” It is usually “Which problem are we trying to change?” A patient may be most troubled by painful cramps. A spouse may be losing sleep because repositioning takes place several times each night. Another family may be focused on anxiety, appetite, or discomfort during prolonged sitting.
During an ALS evaluation, our physicians may review:
Communication deserves special attention. A person with weak speech may need more time, a communication device, or help from a caregiver. We don't treat that as a minor inconvenience. The patient's own goals still need to guide the decision.
Human evidence for cannabinoids in ALS remains limited. Surveys and small studies have explored symptoms such as cramps, spasticity, pain, appetite, sleep, and mood, but those findings don't establish broad effectiveness. A Cochrane review of treatments for ALS-related cramps found that the small randomized THC trial did not show a favorable effect on cramp severity.
That evidence does not prove that every symptom-focused discussion is inappropriate, but it does require honest expectations. Products, doses, cannabinoid ratios, and delivery methods studied elsewhere may also differ from low-THC cannabis prescribed through the Texas program.
We don't tell patients that cannabis protects motor neurons, prolongs survival, restores strength, slows progression, or replaces established ALS therapies. A physician may consider a cautious trial for a specific symptom only when the potential benefit is reasonable in light of the risks and there is a clear plan for judging whether it is helping.
A symptom that seems simple on paper may have several causes. Poor sleep could come from cramps, anxiety, breathing changes, difficulty repositioning, or a mask that no longer fits comfortably. Reduced appetite may reflect mood, fatigue, swallowing difficulty, constipation, medication effects, or the effort required to finish a meal.
That is why ALS care is usually multidisciplinary. Neurology, respiratory therapy, speech-language pathology, nutrition, physical therapy, occupational therapy, palliative care, social work, and durable medical equipment may all matter. Medical cannabis, when prescribed, needs to fit around that care rather than compete with it.
We are especially cautious when swallowing or breathing has changed. Sedation, impaired coordination, or an unsuitable formulation can have more serious consequences for someone who already has a weak cough, aspiration risk, or limited respiratory reserve.
A worthwhile result might be fewer painful nighttime cramps, less distress during repositioning, improved comfort, or better sleep without unacceptable daytime sedation. It isn't a return of lost muscle strength or a halt in disease progression.
The Texas Compassionate Use Program allows qualified participating physicians to prescribe low-THC cannabis to eligible permanent Texas residents. The physician completes the medical evaluation and, when the statutory risk-benefit standard is met, enters the prescription into CURT.
Patients don't register themselves in CURT, submit a separate card application, pay a separate state registration fee, or receive a physical card. A licensed Texas dispensing organization verifies the prescription and the patient or documented legal guardian's identifying information before fulfillment.
Texas currently limits each dosage unit to no more than 10 milligrams of tetrahydrocannabinols, and smoking is not an approved method of medical use. Our guide to the difference between a medical marijuana card and a prescription in Texas explains why the CURT record, not a plastic card, controls legal access.
Our medical marijuana appointment checklist explains how to organize records, medications, symptom notes, and caregiver information.
Focus on the symptom you most want addressed, how it affects daily life, what has already been tried, and what risks are already present. Tell the physician about breathing support, swallowing difficulty, falls, communication needs, and every medication that affects alertness.
Our physicians can review your ALS diagnosis, current symptoms, treatment plan, and whether low-THC cannabis may be appropriate under Texas law.
The visit is a focused medical conversation, not a new ALS diagnosis. We usually begin with the patient's current stage of care and the reason cannabis is being considered now. The answer may come from the patient, a caregiver, or both.
Then we work through the practical details. Has baclofen reduced stiffness but caused too much weakness? Is a sleep medication leaving the patient groggy during transfers? Are cramps painful, or simply visible? Has speech changed enough that yes-or-no questions or an assistive device would make the conversation easier?
Our physicians also ask how benefit will be measured. “Better quality of life” is understandable, but difficult to track. “Wake less often from cramps” or “tolerate evening positioning with less discomfort” gives everyone something clearer to evaluate.
ALS patients often conserve energy for the things that matter most. That means a caregiver may see parts of the day the physician never sees: coughing during meals, difficult transfers, changes in sleep, thicker saliva, a weaker voice late in the day, or confusion after a sedating medication.
Those observations help us judge risk and set a practical target. They don't replace the patient's wishes. Even when speech is difficult, we make room for the person with ALS to participate as directly as possible. An informal caregiver can support the evaluation, but only a legal guardian documented in CURT may act for the patient during dispensing verification.
Families managing age-related medication issues may also find our guide to medical marijuana for seniors in Texas useful.
ALS can reduce the margin for error around sedation, balance, swallowing, and breathing. A side effect that is merely inconvenient for another patient may interfere with communication, transfers, cough strength, eating, or use of respiratory equipment for someone with ALS.
Possible concerns include:
Don't stop riluzole, edaravone, tofersen, baclofen, respiratory treatment, or any other prescribed therapy because cannabis is being considered. Medication and equipment changes belong with the clinicians managing those parts of ALS care.
No. Response and side effects vary. Disease stage, respiratory function, swallowing, cognition, other medications, and prior cannabis exposure can all change the risk-benefit discussion.
Telemedicine may be available when an online medical evaluation is clinically appropriate. That can reduce the effort involved in transportation, wheelchair transfers, respiratory equipment, and prolonged time away from home, but remote care doesn't change the residency, diagnosis, documentation, or prescribing standards.
The physician still needs a reliable way to communicate with the patient, confirm the relevant patient information, review medical history, assess safety, and make an individualized prescribing decision. A caregiver may help with technology or provide observations, but the medical decision remains the physician's.
Yes, with the patient's permission. Caregiver participation can be especially helpful when speech, fatigue, memory, mobility, swallowing, or respiratory equipment makes the visit more complicated. Only a legal guardian documented in CURT may act for the patient during dispensing verification.
The overall cost may include the physician evaluation and medication purchased from a licensed Texas dispensing organization. Product cost depends on the prescribed formulation, dosage, quantity, and dispensing organization. Review the current Texas 420 Doctors pricing page for published consultation and membership information.
Texas doesn't charge patients a separate state registration or medical marijuana card fee. Practice pricing and dispensing-organization pricing are separate.
No. There is no physical state card and no separate patient registration fee. Legal access is based on a physician-entered CURT prescription.
The appointment and prescribing timeline depends on physician availability and whether enough medical information is available to make a responsible decision. A clear diagnosis, current medication list, and useful symptom history can help, but no approval, CURT-entry, verification, or fulfillment time should be guaranteed.
If prescribed, the physician enters the prescription into CURT. A licensed dispensing organization must then verify the prescription and patient information before coordinating fulfillment.
The physician must make the prescribing decision and enter an approved prescription into CURT. A licensed dispensing organization then verifies the prescription and patient information before fulfillment.
An active CURT prescription allows a licensed Texas dispensing organization to verify and fulfill the physician's directions. The patient or documented legal guardian should understand the intended symptom target and which side effects would justify a call or follow-up.
ALS symptoms can change, sometimes quickly. A product that seemed manageable at one point may need reconsideration after a change in swallowing, breathing, cognition, mobility, or medication. Follow-up isn't paperwork. It is where the original goal is compared with what actually happened.
Our guide to what happens after medical marijuana approval in Texas explains dispensary verification and the next practical steps.
Your physician enters the prescription into CURT. A licensed dispensing organization verifies the prescription and patient information before coordinating fulfillment according to the physician's directions.
ALS is a qualifying condition, but only a qualified physician can determine whether the risk of low-THC cannabis is reasonable in light of the potential benefit for a permanent Texas resident. Our team can help you complete the evaluation and understand the CURT process without making assumptions about approval.
Our physicians have never approached ALS as a checkbox diagnosis. The disease can affect strength, speech, swallowing, breathing, mobility, sleep, mood, and the entire caregiving system around the patient. A responsible evaluation has to account for all of that without losing sight of the patient's own priorities.
Our physicians look for one or two realistic symptom goals, review the current care plan, and pay close attention to anything that could increase sedation or reduce safety. Sometimes the right answer is a cautious prescription. Sometimes the risks or timing argue against it. Both decisions require medical judgment.
You can meet our medical marijuana physicians in Texas and review our medical marijuana evaluation services before scheduling.
ALS patients throughout Texas follow the same statewide program. These city guides provide local context while directing patients to the same physician-led evaluation and CURT prescription process.
This page provides general education and doesn't replace diagnosis, ALS specialty care, respiratory assessment, swallowing evaluation, nutrition support, rehabilitation, palliative care, emergency treatment, or individualized medical advice.
Medical cannabis doesn't cure ALS and hasn't been established as a treatment that stops or reverses motor neuron loss. Only a qualified physician can determine whether a permanent Texas resident meets the legal and medical requirements for a low-THC cannabis prescription. Don't stop or change ALS medication, respiratory support, feeding plans, therapy, or another prescribed treatment without guidance from the clinician responsible for that care.
New or rapidly worsening shortness of breath, choking, inability to clear secretions, sudden confusion, severe weakness, chest pain, or another urgent change requires prompt medical attention. A medical marijuana evaluation isn't emergency, respiratory-crisis, or ALS-specialty care.
Yes. ALS is a qualifying condition under the Texas Compassionate Use Program. The patient must also be a permanent Texas resident, and a qualified physician must determine whether the risk of low-THC cannabis is reasonable in light of the potential benefit.
There isn't reliable clinical evidence that medical cannabis slows or reverses ALS progression. It may be considered for selected symptoms, not as a disease-modifying treatment.
The physician may ask about cramps, spasticity, pain, sleep, appetite, anxiety, saliva, mobility, swallowing, breathing, fatigue, and medication side effects.
Our physicians review the ALS diagnosis, current symptoms, medications, respiratory and swallowing concerns, communication needs, caregiver observations, prior cannabis experience, and overall safety.
Neurology notes, an ALS clinic summary, medication lists, respiratory information, and therapy records can help support a complete evaluation. The physician still needs enough reliable information to confirm the diagnosis and make a responsible decision, even when every record isn't available.
Yes. With the patient's permission, a caregiver can help explain symptom changes, medications, communication needs, transfers, swallowing, breathing equipment, and daily care. Only a legal guardian documented in CURT may act for the patient during dispensing verification.
Telemedicine may be available when an online visit is clinically appropriate. The physician must still complete a genuine medical evaluation, confirm the relevant patient information, and make an individualized prescribing decision.
No. Texas doesn't issue a physical card. If prescribed, the physician enters the prescription into CURT. Patients don't register themselves or pay a separate state fee, and a licensed dispensing organization verifies the prescription and patient information before fulfillment.
No. Don't stop or replace prescribed ALS medication without speaking with the neurologist or clinician managing that treatment.
Swallowing difficulty changes the safety discussion and may affect which formulations are appropriate. Tell the physician about choking, aspiration concerns, feeding support, and any recent change in swallowing.
Tell the physician about noninvasive ventilation, respiratory equipment, weak cough, shortness of breath, or other breathing concerns. These details are important when evaluating sedation and overall safety.
The physician enters the prescription into CURT. A licensed Texas dispensing organization verifies the prescription and patient information before coordinating fulfillment according to the physician's directions.
Our physicians can review your diagnosis, symptom priorities, medications, respiratory and swallowing concerns, caregiver input, and whether low-THC cannabis may be appropriate under Texas law.
